Nuclear Medicine: A Key Driver for Sustainable Healthcare in India
DOI:
https://doi.org/10.58213/vidhyayana.v10isi3.2202Keywords:
Theranostics, Sustainable Development Goals (SDG), Nuclear Medicine, Single Positron Emission Computer Tomography (SPECT), Positron Emission Tomography (PET), Sustainable HealthcareAbstract
Nuclear medicine is very well-equipped to make an important contribution to both the SDG and the betterment of the country's healthcare. Health and happiness as the nation works toward "Viksit Bharat" by 2047. Nuclear medicine's sophisticated diagnostic and therapeutic capabilities stand ready to transform healthcare through improved health for all, enhanced disease diagnosis accuracy, and extended treatment options. Nuclear medicine techniques such as SPECT and PET diagnose cancer, heart diseases, and neurological problems earlier, non-invasively, and enable early treatment. The early diagnosis and targeted treatment of millions will bring about health and quality of life improvement through nuclear medicine. It is under the SDG3 goal of healthy lives.
Nuclear medicine is an important element in the health care system of India in dealing with issues of non-communicable diseases such as cancer and heart disease, which demand new forms of treatment. Nuclear medicine involves radiation and imaging in tailoring treatment so that side effects are reduced and procedures not needed are avoided. This makes healthcare more sustainable and accessible and enhances effectiveness and efficiency. India has also upgraded significantly its nuclear medical facilities. The two premier training institutions in terms of nuclear medicine are INMAS and RMC.INMAS promotes innovation, and research while providing quality healthcare services to individuals. Nuclear medicine will be the agent for long-term development in Viksit Bharat by developing an effective healthcare system, high-quality care to all, and equitable access. Its inclusion in our health care system can bring SDG3.
Downloads
References
Lee, D. S., Lee, Y. S., Lee, J. S., & Suh, M. S. (2019). Promotion of nuclear medicine-related sciences in developing countries. Nuclear medicine and molecular imaging, 53, 73-82.
Almansouri, N. E., Awe, M., Rajavelu, S., Jahnavi, K., Shastry, R., Hasan, A., ... & Haider, A. (2024). Early Diagnosis of Cardiovascular Diseases in the Era of Artificial Intelligence: An In-Depth Review. Cureus, 16(3).
Barbet, J., Bernaudin, M., Payoux, P., Cicone, F., Gaugler, M. H., & Kraeber-Bodéré, F. (2020). Editorial: Nuclear Medicine in the Context of Personalized Medicine. Frontiers in medicine, 7, 252. https://doi.org/10.3389/fmed.2020.00252
Gudkov, S. V., Shilyagina, N. Y., Vodeneev, V. A., & Zvyagin, A. V. (2015). Targeted Radionuclide Therapy of Human Tumors. International journal of molecular sciences, 17(1), 33. https://doi.org/10.3390/ijms17010033
Singh, B., Sahani, G., Prasad, V., Watts, A., & Kumar, R. (2023). India's Growing Nuclear Medicine Infrastructure and Emergence of Radiotheranostics in Cancer Care: Associated Challenges and the Opportunities to Collaborate. Indian journal of nuclear medicine: IJNM: the official journal of the Society of Nuclear Medicine, India, 38(3), 201–207. https://doi.org/10.4103/ijnm.ijnm_77_23
Gallach, M., Mikhail Lette, M., Abdel-Wahab, M., Giammarile, F., Pellet, O., & Paez, D. (2020). Addressing Global Inequities in Positron Emission Tomography-Computed Tomography (PET-CT) for Cancer Management: A Statistical Model to Guide Strategic Planning. Medical science monitor: international medical journal of experimental and clinical research, 26, e926544. https://doi.org/10.12659/MSM.926544
Dhoundiyal, S., Srivastava, S., Kumar, S., Singh, G., Ashique, S., Pal, R., Mishra, N., & Taghizadeh-Hesary, F. (2024). Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation. European journal of medical research, 29(1), 26. https://doi.org/10.1186/s40001-023-01627-0
Crișan, G., Moldovean-Cioroianu, N. S., Timaru, D. G., Andrieș, G., Căinap, C., & Chiș, V. (2022). Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade. International journal of molecular sciences, 23(9), 5023. https://doi.org/10.3390/ijms23095023
Crișan, G., Moldovean-Cioroianu, N. S., Timaru, D. G., Andrieș, G., Căinap, C., & Chiș, V. (2022). Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade. International journal of molecular sciences, 23(9), 5023. https://doi.org/10.3390/ijms23095023
Griffeth L. K. (2005). Use of PET/CT scanning in cancer patients: technical and practical considerations. Proceedings (Baylor University. Medical Center), 18(4), 321–330. https://doi.org/10.1080/08998280.2005.11928089
Netala, V. R., Teertam, S. K., Li, H., & Zhang, Z. (2024). A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies. Cells, 13(17), 1471. https://doi.org/10.3390/cells13171471
Hughes S. J. (2012). Nuclear medicine functional imaging of the brain. Clinical medicine (London, England), 12(4), 364–368. https://doi.org/10.7861/clinmedicine.12-4-364
Siegel, K. R., Patel, S. A., & Ali, M. K. (2014). Non-communicable diseases in South Asia: contemporary perspectives. British medical bulletin, 111(1), 31–44. https://doi.org/10.1093/bmb/ldu018
Hyatt, A. (2009). Advancing nuclear medicine through innovation-National Research Council and Institute of Medicine of the National Academies* The National Academies Press, Joseph Henry Press; ISBN-13 978-0-309-11067-9; 2008; £ 28.99. Journal of Radiotherapy in Practice, 8(3), 165-166.
Bajwah, S., Oluyase, A. O., Yi, D., Gao, W., Evans, C. J., Grande, G., Todd, C., Costantini, M., Murtagh, F. E., & Higginson, I. J. (2020). The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers. The Cochrane database of systematic reviews, 9(9), CD012780. https://doi.org/10.1002/14651858.CD012780.pub2
Raghavan, K., Copeland, T. P., Rabow, M., Ladenheim, M., Marks, A., Pantilat, S. Z., O'Riordan, D., Seidenwurm, D., & Franc, B. (2022). Palliative care and imaging utilisation for patients with cancer. BMJ supportive & palliative care, 12(e6), e813–e820. https://doi.org/10.1136/bmjspcare-2018-001572
Pantoja, T., Opiyo, N., Lewin, S., Paulsen, E., Ciapponi, A., Wiysonge, C. S., Herrera, C. A., Rada, G., Peñaloza, B., Dudley, L., Gagnon, M. P., Garcia Marti, S., & Oxman, A. D. (2017). Implementation strategies for health systems in low-income countries: an overview of systematic reviews. The Cochrane database of systematic reviews, 9(9), CD011086. https://doi.org/10.1002/14651858.CD011086.pub2
Hacker, M., Beyer, T., Baum, R. P., Kalemis, A., Lammertsma, A. A., Lewington, V., Talbot, J. N., & Verzijlbergen, F. (2015). Nuclear medicine innovations help (drive) healthcare (benefits). European journal of nuclear medicine and molecular imaging, 42(2), 173–175. https://doi.org/10.1007/s00259-014-2957-6
Echavidre, W., Fagret, D., Faraggi, M., Picco, V., & Montemagno, C. (2023). Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future. Cancers, 15(19), 4839. https://doi.org/10.3390/cancers15194839
Dash, A., Knapp, F. F., & Pillai, M. R. (2013). Targeted radionuclide therapy--an overview. Current radiopharmaceuticals, 6(3), 152–180. https://doi.org/10.2174/18744710113066660023
Choudhury, P. S., & Gupta, M. (2019). Theranostics in India: a Particularly Exquisite Concept or an Experimental Tool. Nuclear medicine and molecular imaging, 53(2), 92–95. https://doi.org/10.1007/s13139-019-00577-y
Vijayakumar, S., Yang, J., Nittala, M. R., Velazquez, A. E., Huddleston, B. L., Rugnath, N. A., Adari, N., Yajurvedi, A. K., Komanduri, A., Yang, C. C., Duggar, W. N., Berlin, W. P., Duszak, R., & Vijayakumar, V. (2022). Changing Role of PET/CT in Cancer Care With a Focus on Radiotherapy. Cureus, 14(12), e32840. https://doi.org/10.7759/cureus.32840
Eary J. F. (2008). PET imaging for Treatment Response in Cancer. PET clinics, 3(1), 101–109. https://doi.org/10.1016/j.cpet.2008.10.001
Sathishkumar, K., Chaturvedi, M., Das, P., Stephen, S., & Mathur, P. (2022). Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India. The Indian journal of medical research, 156(4&5), 598–607. https://doi.org/10.4103/ijmr.ijmr_1821_22
Singh, B., Sahani, G., Prasad, V., Watts, A., & Kumar, R. (2023). India's Growing Nuclear Medicine Infrastructure and Emergence of Radiotheranostics in Cancer Care: Associated Challenges and the Opportunities to Collaborate. Indian journal of nuclear medicine: IJNM : the official journal of the Society of Nuclear Medicine, India, 38(3), 201–207. https://doi.org/10.4103/ijnm.ijnm_77_23
Ringborg, U., von Braun, J., Celis, J., Baumann, M., Berns, A., Eggermont, A., Heard, E., Heitor, M., Chandy, M., Chen, C. J., Costa, A., De Lorenzo, F., De Robertis, E. M., Dubee, F. C., Ernberg, I., Gabriel, M., Helland, Å., Henrique, R., Jönsson, B., Kallioniemi, O., … Yang, H. (2024). Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023. Molecular oncology, 18(2), 245–279. https://doi.org/10.1002/1878-0261.13575
Hricak, H., Ward, Z. J., Atun, R., Abdel-Wahab, M., Muellner, A., & Scott, A. M. (2021). Increasing Access to Imaging for Addressing the Global Cancer Epidemic. Radiology, 301(3), 543–546. https://doi.org/10.1148/radiol.2021211351
Jin, C., Luo, X., Li, X., Zhou, R., Zhong, Y., Xu, Z., Cui, C., Xing, X., Zhang, H., & Tian, M. (2022). Positron emission tomography molecular imaging-based cancer phenotyping. Cancer, 128(14), 2704–2716. https://doi.org/10.1002/cncr.34228
Zhu, A., Lee, D., & Shim, H. (2011). Metabolic positron emission tomography imaging in cancer detection and therapy response. Seminars in oncology, 38(1), 55–69. https://doi.org/10.1053/j.seminoncol.2010.11.012
Khan S. H. (2016). Cancer and positron emission tomography imaging in India: Vision 2025. Indian journal of nuclear medicine: IJNM : the official journal of the Society of Nuclear Medicine, India, 31(4), 251–254. https://doi.org/10.4103/0972-3919.190804
Hricak, H., Abdel-Wahab, M., Atun, R., Lette, M. M., Paez, D., Brink, J. A., Donoso-Bach, L., Frija, G., Hierath, M., Holmberg, O., Khong, P. L., Lewis, J. S., McGinty, G., Oyen, W. J. G., Shulman, L. N., Ward, Z. J., & Scott, A. M. (2021). Medical imaging and nuclear medicine: a Lancet Oncology Commission. The Lancet. Oncology, 22(4), e136–e172. https://doi.org/10.1016/S1470-2045(20)30751-8
Chan, H. P., Liu, W. S., Liou, W. S., Hu, C., Chiu, Y. L., & Peng, N. J. (2020). Comparison of FDG-PET/CT for Cancer Detection in Populations With Different Risks of Underlying Malignancy. In vivo (Athens, Greece), 34(1), 469–478. https://doi.org/10.21873/invivo.11797
Duclos, V., Iep, A., Gomez, L., Goldfarb, L., & Besson, F. L. (2021). PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology. International journal of molecular sciences, 22(8), 4159. https://doi.org/10.3390/ijms22084159
Cutler, C. S., Bailey, E., Kumar, V., Schwarz, S. W., Bom, H. S., Hatazawa, J., Paez, D., Orellana, P., Louw, L., Mut, F., Kato, H., Chiti, A., Frangos, S., Fahey, F., Dillehay, G., Oh, S. J., Lee, D. S., Lee, S. T., Nunez-Miller, R., Bandhopadhyaya, G., … Scott, A. M. (2021). Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project. Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 62(3), 422–430. https://doi.org/10.2967/jnumed.120.247197
OECD/NEA (2019), The Supply of Medical Isotopes: An Economic Diagnosis and Possible Solutions, OECD Publishing, Paris, https://doi.org/10.1787/9b326195-en.
Kumar, R., Singh, B., Singh, H., & Watts, A. (2022). Radiotheranostics Practice in India-Advancing to Precision Oncology. Indian Journal of Nuclear Medicine, 37(Suppl 1), S13-S14.
Urbain, J. L., Scott, A. M., Lee, S. T., Buscombe, J., Weston, C., Hatazawa, J., ... & Wahl, R. (2023). Theranostic radiopharmaceuticals: a universal challenging educational paradigm in nuclear medicine. Journal of Nuclear Medicine, 64(6), 986-991.
Sharma A. R. (2018). Nuclear Medicine in India: A Historical Journey. Indian journal of nuclear medicine: IJNM: the official journal of the Society of Nuclear Medicine, India, 33(Suppl 1), S5–S10. https://doi.org/10.4103/0972-3919.245053
Sitani, K., Parghane, R. V., Talole, S., & Basu, S. (2021). Long-term outcome of indigenous 177Lu-DOTATATE PRRT in patients with metastatic advanced neuroendocrine tumours: a single institutional observation in a large tertiary care setting. The British journal of radiology, 94(1117), 20201041.
Yadav, M. P., Ballal, S., Sahoo, R. K., Tripathi, M., Damle, N. A., Shamim, S. A., ... & Bal, C. (2021). Long-term outcome of 177Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients. PLoS One, 16(5), e0251375.
Bal, C., Ballal, S., & Yadav, M. (2022). A phase II clinical study on 225Ac-DOTATATE therapy in advanced stage gastroenteropancreatic neuroendocrine tumor patients.
Yadav, M. P., Ballal, S., Sahoo, R. K., Tripathi, M., Seth, A., & Bal, C. (2020). Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant prostate cancer patients. Theranostics, 10(20), 9364.
Sen, I., Thakral, P., Tiwari, P., Pant, V., Das, S. S., Manda, D., & Raina, V. (2021). Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy. Annals of Nuclear Medicine, 35(7), 794-810.
Shekhawat, A. S., Singh, B., Malhotra, P., Watts, A., Basher, R., Kaur, H., ... & Radotra, B. D. (2022). Imaging CXCR4 receptors expression for staging multiple myeloma by using 68Ga-Pentixafor PET/CT: comparison with 18F-FDG PET/CT. The British Journal of Radiology, 95(1136), 20211272.
Watts, A., Singh, B., Basher, R., Singh, H., Bal, A., Kapoor, R., ... & Behera, D. (2017). 68Ga-Pentixafor PET/CT demonstrating higher CXCR4 density in small cell lung carcinoma than in non-small cell variant. European journal of nuclear medicine and molecular imaging, 44, 909-910.
Watts, A., Singh, B., Singh, H., Kaur, H., Bal, A., Vohra, M., ... & Behera, D. (2022). 68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings. Journal of Nuclear Medicine Technology, 50(3), 278-281.
Watts, A., Singh, B., Singh, H., Bal, A., Kaur, H., Dhanota, N., ... & Behera, D. (2023). [68Ga] Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors’ density by immunochemistry techniques. European Journal of Nuclear Medicine and Molecular Imaging, 50(4), 1216-1227.
Singh, B., Kaur, H., Parihar, A. S., Watts, A., & Prasad, V. (2022). Precision radiomolecular oncology: Challenging the classical statistical evidence-based medicine. In Biomedical Translational Research: Drug Design and Discovery (pp. 97-110). Singapore: Springer Nature Singapore.
Kumar, P., Nagaraj, C., Joshi, R., Goud, N. S., Kumar, D., Korann, V., ... & Rao, N. P. (2021). Radiosynthesis of [18F] flumazenil for imaging benzodiazepine receptors and its evaluation in human volunteers using simultaneous PET-MRI. Journal of Radioanalytical and Nuclear Chemistry, 329(2), 581-589.
Kumar, P., Thakur, R., Acharya, P. C., Mohan, H. K., Pallavi, U. N., Maheshwari, D., ... & Nagaraj, C. (2022). Synthesis, characterization, and radiosynthesis of fluorine-18-AVT-011 as a Pgp chemoresistance imaging marker. Scientific Reports, 12(1), 18584.
Das, S., Sakhare, N., Kumar, D., Mathur, A., Mirapurkar, S., Sheela, M., ... & Chakraborty, S. (2023). Design, characterization and evaluation of a new 99mTc-labeled folate derivative with affinity towards folate receptor. Bioorganic & Medicinal Chemistry Letters, 86, 129240.
